Chapter 2 pharmacologic principles

Option A: Drugs with a narrow therapeutic index are of the most concern when drug/drug interactions involve inhibition of metabolism. These drugs have a small margin between therapeutic and toxic doses, making them particularly susceptible to changes in metabolism that can lead to adverse effects or therapeutic failure.

Option B: Drugs with a high extraction ratio are less affected by metabolic inhibition since their clearance is primarily dependent on hepatic blood flow rather than metabolic enzyme activity.

Option C: Drugs that are highly polar typically have lower membrane permeability and are less likely to undergo extensive metabolism, making them less of a concern in the context of metabolic inhibition.

Option D: Drugs that are highly bound to albumin may have altered free concentrations due to displacement by other drugs, but this does not directly relate to metabolic inhibition, which primarily affects the metabolism rather than protein binding.

Takeaways: Understanding that drugs with a narrow therapeutic index require careful monitoring during drug/drug interactions involving metabolism inhibition is crucial for patient safety and effective treatment, as these interactions can lead to significant adverse effects or therapeutic failures. For more information on drug interactions and their implications, refer to MedlinePlus on drug interactions.

Option D: All of the above accurately describes drugs with a small volume of distribution (Vd). These drugs typically exhibit limited tissue uptake, making them more concentrated in the plasma. Additionally, their characteristics often allow for effective dialysis in cases of toxicity, and it is a fact that Vd can be less than 5 liters for certain drugs, particularly those that are highly protein-bound or hydrophilic.

Option A: Limited tissue uptake is a characteristic of drugs with a small Vd, as these drugs tend to remain primarily in the bloodstream rather than distribute extensively into tissues.

Option B: Dialysis can be useful in toxicity for drugs with a small Vd, as these drugs are often more readily removed from the bloodstream due to their limited distribution.

Option C: The statement that their Vd cannot be less than 5 liters is false; drugs can indeed have a Vd less than 5 liters, particularly those that are highly polar or bound to plasma proteins.

Takeaways: Understanding the characteristics of drugs with a small volume of distribution (Vd) is crucial for effective management of drug therapy and toxicity, as these drugs often require specific considerations in pharmacokinetics for optimal patient outcomes.

Option C: Protein phosphorylation is the primary mechanism through which insulin exerts its intracellular effects. Insulin binds to its receptor, activating a cascade that leads to the phosphorylation of various proteins, which facilitates glucose uptake and metabolism in cells, particularly in muscle and adipose tissue.

Option A: Changes in ionic concentration within the cell do not directly describe the mechanism of insulin action. While insulin can influence ion transport, its primary action is through protein phosphorylation.

Option B: Changes in membrane potential are not the main mechanism of insulin action. Insulin primarily affects cellular processes through signaling pathways rather than altering membrane potential directly.

Option D: Protein and receptor phosphorylation is partially correct but too broad. The specific mechanism of insulin action focuses on protein phosphorylation within the cell rather than the phosphorylation of the receptor itself, which is a precursor step.

Takeaways: Insulin's intracellular effects are primarily mediated through protein phosphorylation, which enhances glucose uptake and metabolism in target tissues.

Option B: Tetracyclines are effective in treating Lyme disease, which is caused by the bacterium Borrelia burgdorferi. These antibiotics work by inhibiting protein synthesis in bacteria, making them suitable for this specific infection, particularly in early stages of the disease.

Option A: Tetracyclines are not the first-line treatment for infections caused by Clostridium difficile, which typically require antibiotics like vancomycin or fidaxomicin for effective management.

Option C: While tetracyclines can be used for acne vulgaris, they are not primarily indicated for this condition compared to other treatments like topical retinoids or benzoyl peroxide, making this option less accurate in the context of the question.

Option D: Systemic lupus erythematosus is an autoimmune condition that is not treated with tetracyclines; instead, it requires immunosuppressive therapies and corticosteroids for management.

Takeaways: Tetracyclines are specifically indicated for treating Lyme disease due to their antibacterial properties, and understanding their appropriate use is essential for effective patient management, as outlined in CDC guidelines on Lyme disease treatment.

Option D: Obesity & gall stones / Castor oil is wrongly matched as castor oil is a stimulant laxative primarily used for constipation, not for managing obesity or gallstones. Its use in these conditions is not supported by clinical guidelines and may lead to adverse effects.

Option A: After anal surgery / Parrafin oil is accurately matched since paraffin oil is often recommended to soften stools and ease bowel movements post-surgery, promoting healing and comfort.

Option B: Colonic preparation / Bisacodyl is correctly matched as bisacodyl is a commonly used stimulant laxative for bowel preparation before procedures like colonoscopy, ensuring the colon is clear.

Option C: Ingested poison / magnesium sulfate is appropriately matched because magnesium sulfate can be used as an osmotic laxative to help eliminate certain ingested poisons from the gastrointestinal tract.

Takeaways: Understanding the appropriate uses of laxatives, such as the fact that castor oil is not suitable for obesity or gallstones, is crucial for safe pharmacological practices, especially in managing gastrointestinal conditions requiring proper medication administration.

Option D: NF-κB is a key transcription factor that regulates the expression of various genes involved in the inflammatory response. Upon activation, NF-κB translocates to the nucleus and initiates the transcription of pro-inflammatory cytokines, playing a crucial role in mediating inflammation following injury.

Option A: COX-2 is an enzyme that catalyzes the formation of prostaglandins from arachidonic acid, contributing to inflammation but not functioning as a transcription factor.

Option B: HAT refers to histone acetyltransferases, which are involved in modifying histones to regulate gene expression, but they are not classified as transcription factors themselves.

Option C: IκB is an inhibitor of NF-κB that sequesters it in the cytoplasm, preventing its action as a transcription factor until it is degraded, thus not serving as a transcription factor directly.

Takeaways: Understanding the role of NF-κB as a transcription factor in the inflammatory response is essential for recognizing how cellular signaling pathways regulate inflammation and injury responses, which requires knowledge of transcription factors in inflammation for effective clinical practice.

Option B: R-COOR represents an ester functional group, which is highly susceptible to hydrolysis due to the presence of the carbonyl group adjacent to an ether bond. This structure allows for nucleophilic attack by water, leading to the breakdown of the ester into its corresponding acid and alcohol, especially in the presence of an acid or base catalyst.

Option A: R-CO-R denotes a ketone functional group, which is less reactive towards hydrolysis compared to esters. Ketones do not readily undergo hydrolysis under normal conditions due to the stability of the carbonyl group without the adjacent ether bond.

Option C: R-O-R signifies an ether functional group, which is generally resistant to hydrolysis. Ethers require harsher conditions, such as strong acids or high temperatures, to undergo hydrolysis, making them less susceptible than esters.

Option D: R-NH-CH represents an amine functional group, which does not undergo hydrolysis in the same manner as esters. Amines may react with acids or bases, but they do not hydrolyze to form simpler components like esters do.

Takeaways: Understanding the susceptibility of functional groups to hydrolysis is crucial in pharmacology, particularly regarding drug metabolism and stability; esters, such as R-COOR, are notably more prone to hydrolysis than other functional groups, requiring knowledge of chemical reactivity for effective drug design.

Option C: Diphenoxylate is an opioid antidiarrheal agent that is often combined with atropine to discourage misuse. It works by slowing intestinal motility, thereby reducing the frequency of bowel movements and improving stool consistency.

Option A: This option describes the action of adsorbents like kaolin and pectin, which provide a protective coat and adsorb toxins, but does not pertain to diphenoxylate's mechanism.

Option B: Bulk-forming agents, such as psyllium, work by absorbing water to form a gel-like substance, which increases stool bulk and liquidity; this is not the action of diphenoxylate.

Option D: Direct antimicrobial agents target pathogens causing diarrhea and decrease prostaglandin synthesis, but diphenoxylate does not have these properties as it primarily acts on opioid receptors in the gut.

Takeaways: Understanding the mechanism of action for antidiarrheal medications like diphenoxylate, which is an opioid-related combined with atropine, is crucial for effective treatment of diarrhea and requires appropriate patient education on usage and potential side effects.

Option A: Capsule size 5 has the smallest capacity among the options listed, holding approximately 0.13 mL. This size is typically used for smaller doses of medication, making it essential for precise dosing in pharmacology.

Option B: Capsule size 4 has a larger capacity than size 5, holding about 0.2 mL, which makes it unsuitable for the question regarding the smallest capacity.

Option C: Capsule size 1 is even larger, with a capacity of approximately 0.5 mL, further disqualifying it from being the smallest size.

Option D: Capsule size 0 has a capacity of around 0.68 mL, which is significantly larger than size 5, confirming that it does not meet the criteria for the smallest capacity.

Takeaways: Understanding capsule sizes is crucial for accurate medication dosing, as size 5 represents the smallest capacity available for oral capsules, which is important for ensuring proper medication administration.

Option A: Lopinavir, an HIV-protease inhibitor, is associated with lipodystrophy syndrome, which includes changes in body fat distribution, such as fat accumulation in the abdomen and loss of fat in the face and limbs. This side effect is significant in the management of patients on antiretroviral therapy.

Option B: While hyperglycemia can occur with some antiretroviral medications, it is not a primary association with lopinavir specifically. Other medications in the class are more commonly linked to this side effect.

Option C: Peripheral neuropathy is more commonly associated with other antiretroviral agents, such as stavudine and didanosine, rather than with lopinavir, which does not typically cause this condition.

Option D: Lactic acidosis is primarily associated with nucleoside reverse transcriptase inhibitors (NRTIs) like zidovudine and didanosine, not with protease inhibitors like lopinavir.

Takeaways: Lopinavir is notably linked to lipodystrophy syndrome, which requires careful monitoring and patient education regarding body composition changes during treatment with antiretroviral therapy, including guidelines on managing lipodystrophy.

Option B: Dose dumping is a significant concern in the formulation of modified-release drug products, where the intended gradual release of medication can be compromised, leading to an unintended rapid release of the drug into the bloodstream. This can result in toxicity or adverse effects due to higher-than-expected drug concentrations.

Option A: Compressed tablets typically do not exhibit dose dumping; they are designed for immediate release and do not have the same controlled release mechanisms as modified-release formulations.

Option C: Hard gelatin capsules generally allow for consistent drug release and do not inherently lead to dose dumping unless improperly formulated.

Option D: Soft gelatin capsules are also designed for consistent release and do not typically present a dose dumping issue unless specific formulation problems occur.

Takeaways: Understanding the risks associated with modified-release drug products is crucial for safe medication management, as improper formulation can lead to dose dumping, requiring careful monitoring and patient education to prevent adverse effects.

Option B: Intravenous co-trimoxazole is the first-line treatment for Pneumocystis carinii pneumonia (PCP) in patients with HIV infection, providing effective antimicrobial coverage against this opportunistic infection. It combines sulfamethoxazole and trimethoprim, targeting the organism's folate synthesis pathway, which is crucial for its survival. This treatment is essential in managing PCP, especially in immunocompromised patients.

Option A: Aztreonam is a monobactam antibiotic effective against Gram-negative bacteria but does not have activity against Pneumocystis carinii, making it unsuitable for treating PCP.

Option C: Rifabutin is primarily used for the prevention and treatment of tuberculosis and does not target Pneumocystis carinii, thus not applicable for PCP management.

Option D: Pentamidine is an alternative treatment for PCP but is not the first-line therapy. It is typically reserved for cases where co-trimoxazole cannot be used due to allergies or resistance.

Takeaways: Co-trimoxazole is the primary treatment for Pneumocystis carinii pneumonia in HIV patients, as it effectively inhibits folate synthesis in the organism, requiring appropriate management strategies for opportunistic infections in immunocompromised individuals.

Option D: A and B are the most serious adverse effects of morphine, with respiratory depression being particularly critical as it can lead to hypoxia and death. Dependence also poses significant risks, especially with long-term use, making both effects vital considerations in patient management.

Option A: Dependence is a serious concern with morphine, but it is not as immediately life-threatening as respiratory depression, which can occur acutely and requires urgent intervention.

Option B: Respiratory depression is indeed a serious adverse effect of morphine, but it is not the only one; dependence also significantly impacts patient safety and treatment outcomes.

Option C: Hypertension is not a common or serious adverse effect associated with morphine use; rather, morphine typically causes hypotension due to its vasodilatory effects.

Takeaways: Understanding the serious adverse effects of morphine, particularly respiratory depression and dependence, is crucial for safe opioid management and requires appropriate monitoring and patient education to mitigate risks.

Option C: Ribose is the sugar inherent in RNA, while deoxyribose is the sugar found in DNA. Both sugars are essential components of the nucleotides that make up these nucleic acids, playing a crucial role in genetic information storage and transfer.

Option A: Glucose is a simple sugar that serves as a primary energy source for cells but is not a component of nucleic acids.

Option B: Sucrose is a disaccharide composed of glucose and fructose, primarily involved in energy metabolism, and does not form part of RNA or DNA.

Option D: Digitoxose is a sugar derivative found in certain cardiac glycosides and is not related to the structure of nucleic acids.

Takeaways: Ribose is the sugar that forms part of RNA, while deoxyribose is found in DNA, highlighting the importance of these sugars in genetic material structure and function, which requires understanding nucleic acid composition for effective study in pharmacology.